Patents by Inventor Thomas Haffner

Thomas Haffner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7859691
    Abstract: A process enables a user to alter all the operational modes of a printer through a single parameter selection. The process includes selecting a group of operational parameter sets for a print process, the group selection being made with reference to one of an operational mode and a characteristic parameter; and selecting a set of operational parameters from the selected group of operational parameter sets, the set selection being made with reference to the other of the operational mode and the characteristic parameter.
    Type: Grant
    Filed: June 2, 2006
    Date of Patent: December 28, 2010
    Assignee: Xerox Corporation
    Inventors: Trevor James Snyder, Cheng-Sung (Joel) Chan, Walter Sean Harris, Paul Jeremy Woodward, Shell Thomas Haffner, James B. Campbell
  • Publication number: 20070279665
    Abstract: A process enables a user to alter all the operational modes of a printer through a single parameter selection. The process includes selecting a group of operational parameter sets for a print process, the group selection being made with reference to one of an operational mode and a characteristic parameter; and selecting a set of operational parameters from the selected group of operational parameter sets, the set selection being made with reference to the other of the operational mode and the characteristic parameter.
    Type: Application
    Filed: June 2, 2006
    Publication date: December 6, 2007
    Inventors: Trevor James Snyder, Cheng-Sung (Joel) Chan, Walter Sean Harris, Paul Jeremy Woodward, Shell Thomas Haffner, James B. Campbell
  • Publication number: 20050208156
    Abstract: The invention relates to the novel use of plants and plant extracts for treating schizophrenia. Said plants and plant extracts are selected from St John's wort, gingko, saffron and ginseng. The use of said substances occurs preferably in conjunction with conventional psychotherapeutic drugs, i.e. in the form of a preparation combining standard medicaments for treating schizophrenia for the simultaneous, separate or graduated use in case of schizophrenia. The invention also relates to methods for treating schizophrenia.
    Type: Application
    Filed: March 25, 2003
    Publication date: September 22, 2005
    Applicant: Lichtwer Pharma GmbH
    Inventors: Michael Ploch, Harald Murck, Thomas Haffner
  • Publication number: 20040234674
    Abstract: The invention relates to artichoke leaf extracts (Cynarae folium) that are characterized by defined absolute percentages and relative inherent percentages of typical constituents of artichoke leaves such as caffeoyl quinic acids and flavonoids The activity spectrum of the inventive leaf extracts is substantially different from known artichoke leaf extracts, said inventive leaf extracts also being different from each other. The invention also relates to methods for producing the extracts and to fields of application thereof.
    Type: Application
    Filed: June 29, 2004
    Publication date: November 25, 2004
    Inventors: Jurgen Eich, Thomas Haffner, Thomas Goerke, Werner Schneider